Spinal Fusion Devices Market Size, Share & Trends Analysis Report by Product, Applications, Regions and Segment Forecasts, 2020 – 2027

Besides exploring the company profiles of prominent market leaders, the research gather and analyses raw data on the regulatory framework, cost structure, import and export status, supply chain management and supply chain management expected to shape the trajectory of the business landscape. The researchers behind the study have further leveraged the industry-leading assessment tools to gauge the growing level of competition, recent acquisition and mergers, product launches and new entrants. The global Spinal Fusion Devices Market will be worth USD 8.90 Billion by 2027, according to a current analysis by Emergen Research.

Advertisements

Key Highlights From The Report

In November 2019, DePuy Synthes Companies launched the SYMPHONY Occipito-Cervico-Thoracic (OCT) System. The newly launched system by the company is expected to help in the surgical treatment of conditions in the neck and upper back. The system includes a set of implants and instruments which can be used for the stabilization of the spine in patients undergoing Posterior Cervical Fusion Surgery.

The thoracolumbar devices segment held the largest market share of 45.3% in 2019. The rising aging population and their increasing demand for spinal care are expected to drive the growth of thoracolumbar devices.

Minimally Invasive Spine Surgery is forecasted to grow with the fastest CAGR of 4.0% over the forecast period. The risks associated with open surgeries are contributing to the growing adoption of the Minimally Invasive Spine Surgery by Healthcare professionals.

The Hospitals & Ambulatory segment held the largest market share of the Spinal Fusion Devices in 2019. The presence of favorable health insurance coverage for most of the spinal treatments and the availability of skilled spine surgeons in the hospitals is expected to drive the demand of the segment.

The Asia Pacific region is expected to be the fastest-growing region over the forecast period due to the increasing healthcare budgetary allocation in the emerging economies.

Key participants include Braun Melsungen, Alphatec Holdings, Inc., Exactech, Inc., DePuy Synthes Companies (Johnson & Johnson Services, Inc.), Medtronic PLC, Globus Medical, Inc., NuVasive, Inc., Stryker Corporation, Orthofix International N.V., and Zimmer Biomet Holdings, Inc., among others.

Regional scope- North America; Europe; Asia Pacific; Central & South America; MEA

Product Outlook (Revenue, USD Billion; 2017-2027)

Cervical Fixation Devices

Thoracolumbar Devices

Interbody Fusion Devices

Biologics

Surgery Outlook (Revenue, USD Billion; 2017-2027)

Minimally Invasive Spine Surgery

Open Spine Surgery

End User Outlook (Revenue, USD Billion; 2017-2027)

Specialty Clinics

Hospitals & Ambulatory Surgery Centers

Others